Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus"

被引：1
|
作者：
Kato, Eri T. [1 ]
Sabatine, Marc S. [2 ]
Wiviott, Stephen D. [2 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
[2] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA
来源：
CIRCULATION | 2019年 / 140卷 / 18期
关键词：
D O I：
10.1161/CIRCULATIONAHA.119.042848
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E740 / E741
页数：2
相关论文
共 50 条
  • [41] Letter by Zhang et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors"
    Zhang, Jian
    Lan, Hui-yao
    Wan, Song
    CIRCULATION, 2019, 139 (05) : 718 - 719
  • [42] Letter by Jian et al Regarding Article, "Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes Mellitus"
    Jian, Wen
    Li, Lang
    Gui, Chun
    CIRCULATION, 2021, 143 (02) : e5 - e6
  • [43] Response to Letter Regarding Article 'Heart failure in adults with congenital heart disease'
    Gil, Fernando Riesgo
    Brida, Margarita
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 367 : 26 - 26
  • [44] Letter by Singh et al Regarding Article, "Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)"
    Singh, Jagdeep S.
    Struthers, Allan D.
    Lang, Chim C.
    CIRCULATION, 2021, 144 (03) : E38 - E39
  • [45] Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"
    Koh, Kwang Kon
    CIRCULATION, 2019, 139 (03) : 416 - 417
  • [46] Letter by Tanaka and Node Regarding Article, "Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study"
    Tanaka, Atsushi
    Node, Koichi
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (01): : 118 - 119
  • [47] Letter regarding article by Staat et al, "Postconditioning the human heart" -: Reply
    Staat, P
    Rioufol, G
    Bonnefoy, E
    Finet, G
    André-Fouët, X
    Ovize, M
    Piot, C
    Cung, TT
    Cottin, Y
    L'Huillier, I
    Aupetit, JF
    CIRCULATION, 2006, 113 (12) : E665 - E665
  • [48] Response to Letter Regarding Article, "Endogenous Erythropoietin and Outcome in Heart Failure"
    Belonje, Anne M. S.
    Voors, Adriaan A.
    van der Meer, Peter
    Jaarsma, Tiny
    van Veldhuisen, Dirk J.
    van Gilst, Wiek H.
    CIRCULATION, 2010, 122 (10) : E450 - E450
  • [49] Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"
    Tampakis, Athanasios
    Tampaki, Ekaterini Christina
    Gurke, Lorenz
    CIRCULATION, 2018, 138 (08) : 848 - 849
  • [50] Letter by Beldhuis et al Regarding Article, "Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure"
    Beldhuis, Iris E.
    Damman, Kevin
    ter Maaten, Jozine M.
    CIRCULATION-HEART FAILURE, 2022, 15 (01)
12345